Patents by Inventor Christoph Binkert
Christoph Binkert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9000018Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: July 26, 2013Date of Patent: April 7, 2015Assignee: Actelion Pharmaceuticals, LtdInventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Publication number: 20130310432Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: ApplicationFiled: July 26, 2013Publication date: November 21, 2013Applicant: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: 8524752Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: August 9, 2012Date of Patent: September 3, 2013Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Publication number: 20120302612Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: ApplicationFiled: August 9, 2012Publication date: November 29, 2012Inventors: Christoph BINKERT, Martin BOLLI, Boris MATHYS, Claus MUELLER, Michael SCHERZ, Oliver NAYLER
-
Patent number: 8273779Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: July 2, 2009Date of Patent: September 25, 2012Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: 8067419Abstract: The invention relates to novel piperazine derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and their use as medicaments for the treatment or prevention of protozoal infections, especially malaria.Type: GrantFiled: October 20, 2006Date of Patent: November 29, 2011Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Christoph Boss, Olivier Corminboeuf, Corinna Grisostomi, Solange Meyer
-
Patent number: 7937660Abstract: A stent-graft planning system is a web-based system that assists a physician in selecting and ordering the right stent-graft online in real-time. The stent-graft planning system provides a physician with a two-dimensional (2D) graphic model reflecting the individual vessel anatomy, e.g., aneurismal anatomy, and the selected stent graft in that anatomy. By comparing the graphic model with the image of the patient's vessels, the physician can note any dimensions that are inconsistent with the graphic image and problems with the stent-graft placement. Each collected measurement is validated and the physician is warned if the measurement suggests a problem. The stent-graft system automatically generates the most suitable stent graft for an individual patient. After reviewing the selected stent graft in the 2D model, the stent graft can be ordered online.Type: GrantFiled: April 18, 2003Date of Patent: May 3, 2011Assignee: Medtronic Vascular, Inc.Inventor: Christoph A. Binkert
-
Patent number: 7875726Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: June 3, 2008Date of Patent: January 25, 2011Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: 7626037Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: February 5, 2008Date of Patent: December 1, 2009Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Publication number: 20090275625Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: ApplicationFiled: July 2, 2009Publication date: November 5, 2009Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Publication number: 20090018641Abstract: Large cell stents can be made having a plurality of cylindrical segments; and a plurality of connectors that join the segments to form a hollow tube, in which each segment comprises a series of support elements joined end to end at turning points in a zig-zag pattern to form a cylinder; a first segment is joined to a second segment by a plurality of connectors, each connector connecting a turning point of a first segment to a corresponding turning point of a second segment; and cells of the stent comprise two support elements in a first segment, one connector, two support elements in a second adjacent segment, and a second connector, all connected in series to form a continuous line. In some embodiments, each turning point in the first segment is longitudinally aligned with turning point in the second segment.Type: ApplicationFiled: March 24, 2006Publication date: January 15, 2009Inventor: Christoph Binkert
-
Publication number: 20080280962Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: ApplicationFiled: June 3, 2008Publication date: November 13, 2008Applicant: ACTELION PHARMACEUTICALS, LTD.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: 7435828Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4- one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: November 16, 2004Date of Patent: October 14, 2008Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Publication number: 20080234272Abstract: The invention relates to novel piperazine derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and their use as medicaments for the treatment or prevention of protozoal infections, especially malaria.Type: ApplicationFiled: October 20, 2006Publication date: September 25, 2008Applicant: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Christoph Boss, Olivier Corminboeuf, Corinna Grisostomi, Solange Meyer
-
Publication number: 20080146629Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: ApplicationFiled: February 5, 2008Publication date: June 19, 2008Applicant: ACTELION PHARMACEUTICALS, LTD.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: 7375227Abstract: The invention relates to novel 1-pyridin-4-yl urea derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists.Type: GrantFiled: December 2, 2002Date of Patent: May 20, 2008Assignee: Actelion Pharmaceuticals Ltd.Inventors: Hamed Aissaoui, Christoph Binkert, Martine Clozel, Boris Mathys, Claus Mueller, Oliver Nayler, Michael Scherz, Jörg Velker, Thomas Weller
-
Patent number: 7237196Abstract: A stent-graft planning system is a web-based system that assists a physician in selecting and ordering the right stent-graft online in real-time. The stent-graft planning system includes a graphic user interface that provides a physician with a two-dimensional (2D) graphic model reflecting the individual vessel anatomy, e.g., aneurismal anatomy, and the selected stent graft in that anatomy. A data entry region in the graphic user interface is used in collecting each measurement. A stent-graft planning progress guide region of the graphic user interface tells a user the active step in the stent-graft-planning process. A navigation region of the graphic user interface includes features for navigating the stent-graft planning process.Type: GrantFiled: April 18, 2003Date of Patent: June 26, 2007Assignee: Medtronic Vascular, Inc.Inventors: Christoph A. Binkert, Markus Almer
-
Patent number: RE43728Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: November 16, 2004Date of Patent: October 9, 2012Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: RE43833Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: August 9, 2011Date of Patent: November 27, 2012Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
-
Patent number: RE45174Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.Type: GrantFiled: September 17, 2013Date of Patent: September 30, 2014Assignee: Actelion Pharmaceuticals Ltd.Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler